Literature DB >> 3303347

Determinants of bile formation during development: ontogeny of hepatic bile acid metabolism and transport.

F J Suchy, J C Bucuvalas, D A Novak.   

Abstract

The studies cited in this brief review stress that the development of hepatic transport processes is extraordinarily complex. Important changes in hepatic morphology and synthetic capacity are required before maturation of membrane carriers for bile acids. Transport systems at both poles of the hepatocyte develop independently. An increase in bile acid synthesis at several stages during the development appears to be an ontogenic event that is programmed to occur in concert with functional maturation of the enterohepatic circulation. Expression of specific membrane transporters for bile acids can be observed in fetal liver and postnatal ileum during periods of expansion of the bile acid pool. It is likely that specific defects, such as congenitally absent or defective bile acid transport proteins, will eventually be discovered in rare patients with undefined cholestatic syndromes. The absence of active ileal bile acid transport has recently been demonstrated in several children with congenital bile acid malabsorption. Whether bile acids can actually induce or regulate production of their own carriers during development has not been determined, but an increase in bile acid pool through feeding of exogenous bile acid has been shown to stimulate an increase in plasma membrane carriers for bile acids in adult rat liver. Thus, a number of factors, including available driving forces for transport, bile acid pool size and composition, effectiveness of intracellular compartmentation and transfer, and the function of membrane carriers, can all contribute to low rates of bile flow and bile acid secretion, depending on the stage of development.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3303347     DOI: 10.1055/s-2008-1040567

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  7 in total

1.  Neonatal pharmacology: extensive interindividual variability despite limited size.

Authors:  Cuneyt Tayman; Maisa Rayyan; Karel Allegaert
Journal:  J Pediatr Pharmacol Ther       Date:  2011-07

2.  Evidence for defective primary bile acid secretion in children with progressive familial intrahepatic cholestasis (Byler disease).

Authors:  E Jacquemin; M Dumont; O Bernard; S Erlinger; M Hadchouel
Journal:  Eur J Pediatr       Date:  1994-06       Impact factor: 3.183

3.  Phytosterols promote liver injury and Kupffer cell activation in parenteral nutrition-associated liver disease.

Authors:  Karim C El Kasmi; Aimee L Anderson; Michael W Devereaux; Padade M Vue; Wujuan Zhang; Kenneth D R Setchell; Saul J Karpen; Ronald J Sokol
Journal:  Sci Transl Med       Date:  2013-10-09       Impact factor: 17.956

4.  The hepatic bile acid transporters Ntcp and Mrp2 are downregulated in experimental necrotizing enterocolitis.

Authors:  Nathan J Cherrington; Teresa E Estrada; Harrison A Frisk; Mark J Canet; Rhiannon N Hardwick; Bohuslav Dvorak; Katie Lux; Melissa D Halpern
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-11-01       Impact factor: 4.052

5.  Role of organic anion-transporting polypeptides, OATP-A, OATP-C and OATP-8, in the human placenta-maternal liver tandem excretory pathway for foetal bilirubin.

Authors:  Oscar Briz; Maria A Serrano; Rocio I R MacIas; Javier Gonzalez-Gallego; Jose J G Marin
Journal:  Biochem J       Date:  2003-05-01       Impact factor: 3.857

Review 6.  A framework for assessing risks to children from exposure to environmental agents.

Authors:  George Daston; Elaine Faustman; Gary Ginsberg; Penny Fenner-Crisp; Stephen Olin; Babasaheb Sonawane; James Bruckner; William Breslin; Tara J McLaughlin
Journal:  Environ Health Perspect       Date:  2004-02       Impact factor: 9.031

7.  Ontogeny Related Changes in the Pediatric Liver Metabolome.

Authors:  Christopher M Wilson; Qian Li; Roger Gaedigk; Charlie Bi; Saskia N de Wildt; J Steven Leeder; Brooke L Fridley
Journal:  Front Pediatr       Date:  2020-09-29       Impact factor: 3.418

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.